Elghandour had been a principal at Johnson & Johnson Development Corporation (JJDC) for four years and would join Nevro, according to news provider Fortune.
Rami Elghandour (pictured) has moved from healthcare company Johnson & Johnson’s corporate venturing unit to one of its portfolio companies as head of strategy and business development.
Elghandour had been a principal at Johnson & Johnson Development Corporation (JJDC) for four years and would join Nevro, which makes medical devices to treat chronic pain and other neurological disorders, according to news provider Fortune.
Elghandour helped lead JJDC’s series B investment in Nevro.
In July last years, JJDC led the $58m…
